Skip to main content

Management of the Patient With Mitochondrial Disease in the Neurosciences Critical Care Unit

  • Chapter

Part of the book series: Current Clinical Neurology ((CCNEU))

Abstract

The term mitochondrial disorder (MD) encompasses a group of diseases that result from the structural, biochemical, or genetic derangement of mitochondria. In simple terms, MDs are disorders of deficient cellular energy production (1). The role of MD in aging and in a wide variety of systemic and neurologic disorders is increasingly recognized (2). Mitochondrial disorders may present as independent syndromes, complicate other medical disorders, or occur as complication of therapies used to treat other disorders (1). Most patients with MD are not diagnosed on initial presentation but present with recurrent episodic symptoms that elude diagnosis for months to years.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Clay AS, Behnia M, Brown KK. Mitochondrial disease. Chest 2001; 120: 634–648.

    Article  PubMed  CAS  Google Scholar 

  2. Graeber MB, Muller U. Recent developements in the molecular genetics of mitochondrial disorders. J. Neurol. Sci. 1998; 153: 251–263.

    Article  PubMed  CAS  Google Scholar 

  3. Hanna MG, Nelson IP. Genetics and molecular pathogenesis of mitochondrial respiratory chain diseases. CMLS 1999; 55: 691–706.

    Article  PubMed  CAS  Google Scholar 

  4. Flier JS, Underhill L. Mitochondrial DNA and disease. N. Engl. J. Med. 1995; 333: 638–644.

    Article  Google Scholar 

  5. Johns JR. Mitochondrial DNA and disease. N. Engl. J. Med. 1995; 333: 638–644.

    Article  PubMed  CAS  Google Scholar 

  6. Leonard JV, Schapira AHV. Mitochondrial respiratory chain disorders I: Mitochondrial DNA defects. Lancet 2000; 355: 389–394.

    Article  PubMed  CAS  Google Scholar 

  7. Leonard JV, Schapira AHV. Mitochondrial respiratory chain disorders II: Mitochondrial DNA defects. Lancet 2000; 355: 389–394.

    Article  PubMed  CAS  Google Scholar 

  8. Schapira AHV. Mitochondrial disorders. Curr. Opin. Neurol. 2000; 13: 526–532.

    Article  Google Scholar 

  9. Chinnery PF, Turnbull DM. Epidemiology and treatment of mitochondrial disorders. Am. J. Med. Genet. 2001; 106: 94–101.

    Article  PubMed  CAS  Google Scholar 

  10. Griggs RC, Karpati G. Muscle pain, fatigue, and mitochondriopathies. N. Engl. J. Med. 1999; 341: 1076–1078.

    Article  Google Scholar 

  11. Howard RS, Russsell S, Losseff N, et al. Management of mitochondrial disease in the critical care unit. QJM 1995; 88: 197–207.

    PubMed  CAS  Google Scholar 

  12. Dandurand R, Matthews PM, Arnold DL, Eidelman DH. Mitochondrial disease-pulmonary function, excercise performance, and blood lactate levels. Chest 1995; 108: 182–189.

    Article  PubMed  CAS  Google Scholar 

  13. Kimura S, Ohtuki N, Nezu A, Tanaka M, Takeshita S. Clinical and radiological improvements in mitochondrial encephalomyelopathy following sodium dichloroacetate therapy. Brain Dev. 1997; 19: 535–540.

    Article  PubMed  CAS  Google Scholar 

  14. Bargiela-Lemos A, Mosquera J, Mate A, Sirvent J. Myopathy with mitochondrial changes presenting as respiratory failure in two brothers. Pediatr. Pulmonol. 1999; 27: 213–217.

    Article  Google Scholar 

  15. Barohn RJ, Clanton T, Sahenk Z, Mendell JR. Recurrent respiratory insufficiency and depressed ventilatory drive complicating mitochondrial myopathies. Neurology 1990; 40: 103–106.

    Article  PubMed  CAS  Google Scholar 

  16. Penniso-Besnier I, Reynier P, Asfar P, et al. Recurrent brain hematomas in MELAS associated with an ND5 gene mitochondrial mutation. Neurology 2000; 55: 317–318.

    Article  Google Scholar 

  17. Molnar MJ, Valikovics A, Molnar S, et al. Cerebral blood flow and glucose metabolism in mitochondrial disorders. Neurology 2000; 55: 544–548.

    Article  PubMed  CAS  Google Scholar 

  18. Cros D, Palliyath S, DiMauro S, Ramirez C, Shamsia M, Wizer B. Respiratory failure revealing mitochondrial myopathy in adults. Chest 1992; 101: 824–828.

    Article  PubMed  CAS  Google Scholar 

  19. Borel CO, Guy J. Ventilatory management in critical neurologic illness. In: KG J (ed). Neurologic Clinics. Philadelphia: Saunders Company, 1995: 627–644.

    Google Scholar 

  20. Cray SH, Robinson BH, Cox PN. Lactic acidemia and bradyarrhythmia in a child sedated with propofol. Crit. Care Med. 1998; 26: 2087–2092.

    Article  PubMed  CAS  Google Scholar 

  21. Guilleminault C, Phillip P, Robinson A. Sleep and neuromuscular disease: bilevel positive airway pressure by nasal mask as a treatment for sleep disordered breathing in patients with neuromuscular disease. J. Neurol. Neurosurg. Psychiatry 1998; 65: 225–232.

    Article  PubMed  CAS  Google Scholar 

  22. Pfeiffer G, Winkler G, Neunzig P, Wolf W, Thayssen G, Kunze K. Long-term management of acute respiratory failure in metabolic myopathy. Intensive Care Med. 1996; 22: 1406–1409.

    Article  PubMed  CAS  Google Scholar 

  23. Desnuelle C, Pellissier J, Serratrice G. Chronic progressive external ophtalmoplegia (CPEO) associated with diaphragmatic paralysis: succesful treatment with coenzyme Q (CoQ). Neurology 1988; 38: 102.

    Google Scholar 

  24. Tanahashi C, Nakayama A, Yoshida M, Ito M, Hashizume Y. MELAS with the mitochondrial DNA 3243 point mutation: a neuropathological study. Acta. Neuropathol. 2000; 99: 31–38.

    Article  PubMed  CAS  Google Scholar 

  25. Yoneda M, Maeda M, Kimura H, Fujii A, Katayama K, Kuriyama M. Vasogenic edema on MELAS: A serial study with diffusion-weighted MR imaging. Neurology 2001; 53: 2182–2184.

    Article  Google Scholar 

  26. Adams HP, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke. Circulation 1996; 94: 1167–1174.

    Article  PubMed  Google Scholar 

  27. Broderick JP, Adams HP, Barsan W, et al. Guidelines for the management of spontaneous intracerebral hemorrhage-A statement for healthcare professionals from a special Wwriting group of the stroke council, American Heart Association. Stroke 1999; 30: 905–915.

    Article  PubMed  CAS  Google Scholar 

  28. Canafoglia L, Franceschetti S, Antozzi C, et al. Epileptic phenotypes associated with mitochondrial disorders. Neurology 2001; 56: 1340–1346.

    Article  PubMed  CAS  Google Scholar 

  29. Lowenstein DH, Alldredge B. Status epilepticus. N. Engl. J. Med. 1998; 338: 970–976.

    Article  PubMed  CAS  Google Scholar 

  30. Prasad A, Worrall BB, Bertram EH, Bleck TP. Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia 2000; 42: 380–386.

    Article  Google Scholar 

  31. Matsumoto J, Ogawa H, Maeyama R, et al. Successful treatment by direct hemoperfusion of coma possibly resulting from mitochondrial dysfunction in acute valproate intoxication. Epilepsia 1997; 38: 950–953.

    Article  PubMed  CAS  Google Scholar 

  32. Absalon MJ, Harding CO, Fain DR, Mack KJ. Leigh syndrome in an infant resulting from mitochondrial DNA depletion. Pediatr. Neurol. 2001; 24: 60–63.

    Article  PubMed  CAS  Google Scholar 

  33. Young GB, DeRubies DA. Metabolic encephalopathies. In: Young GB, Ropper AH, Bolton CF (eds). Coma and Impaired Consciousness. New York: McGraw-Hill, 1998: 307–392.

    Google Scholar 

  34. Lin Y-C, Lee W-T, Wang P-J, Shen Y-Z. Vocal cord paralysis and hypoventilation in a patient with suspected Leigh disease. Pediatr. Neurol. 1999; 20: 223–225.

    Article  PubMed  CAS  Google Scholar 

  35. Araki S, Hayashi M, Yasaka A, Maruki K. Electrophysiologic brainstem dysfunction in a child with Leigh disease. Pediatr. Neurol. 1997; 16: 329–333.

    Article  PubMed  CAS  Google Scholar 

  36. Marino PL. The organic acidosis. In: Marino PL (ed). The ICU Book, 2nd ed. Baltimore: Williams and Wilkins, 1998: 592–607.

    Google Scholar 

  37. Pincus JH, Itokawa Y, Cooper JR. Enzyme inhibiting factor in subacute necrotizing encephalomyelopathy. Neurology 1969; 19: 841–844.

    Article  PubMed  CAS  Google Scholar 

  38. North JB, Jennett S. Abnormal breathing patterns associated with acute brain damage. Arch. Neurol. 1974; 31: 338–342.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

Chalela, J.A. (2004). Management of the Patient With Mitochondrial Disease in the Neurosciences Critical Care Unit. In: Suarez, J.I. (eds) Critical Care Neurology and Neurosurgery. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-660-7_31

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-660-7_31

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-350-3

  • Online ISBN: 978-1-59259-660-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics